Yes. For assay development, we provide matrix-matched clinical specimens, known-status positives and negatives, and diverse demographic panels through both our biorepository and prospective collections. For analytical validation—sensitivity, specificity, limit of detection, precision, reference intervals, stability— we design specimen panels to your study protocol with the metadata depth your regulatory package requires.
Can DCN Dx support assay development and analytical validation?
May 31 2026
- FAQ





